Gene-based therapy may slow development of life-threatening heart condition

A new study in mice shows that replacement of a dysfunctional gene could prolong survival in some people with arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare inherited disorder in which the muscular walls of the heart progressively weaken and put patients at risk of dangerous irregular heartbeats.

This article was originally published on

You may also be interested in:

Read More:

Lawyers Lookup